The Keeping Drugs Out of Schools Act of 2025 establishes a federal grant program to fund partnerships between community coalitions and local schools for evidence-based drug prevention programs. Eligible entities - community coalitions with existing federal grants and formal agreements with at least one school - can receive up to $75,000 annually per school partnership to implement tailored prevention strategies. Funds must supplement, not replace, existing school drug prevention funding, and grantees must submit detailed implementation plans. The program authorizes $7 million annually from 2026 through 2031 to support these school-community partnerships.
HR 2527, the Early Detection of Vision Impairments for Children Act of 2025, provides federal grants to states, territories, tribes, and urban Indian organizations to establish statewide vision screening and intervention programs for children. The bill requires grantees to implement vision screenings in medical, home, educational, and early learning settings, develop data systems for tracking outcomes, and improve access to care for underserved children in rural and low-income communities. It also authorizes technical assistance grants through the CDC to help develop screening systems, share best practices, and conduct research on vision care programs. The bill allocates $5 million annually for fiscal years 2026-2030 to fund these activities, targeting early detection to prevent vision-related learning and developmental challenges.
HR 1051 amends the Federal Food, Drug, and Cosmetic Act to allow generic drug manufacturers (subsequent applicants) to receive drug approval if the first applicant fails to begin commercial marketing within 33 months of their application. The bill requires subsequent applicants to certify they can start marketing within 75 days of approval and mandates that they begin marketing within that window or lose their approval. If marketing is delayed due to unforeseen events, applicants must provide specific certification to regain approval eligibility. This directly affects generic drug companies seeking to enter the market after a brand-name drug's exclusivity period lapses.
The Caring for All Families Act expands family medical leave eligibility under the FMLA to include domestic partners, adult children, children of domestic partners, and extended family members such as grandparents, grandchildren, siblings, and in-laws. It also adds new "parental involvement and family wellness" leave allowing employees to attend school activities for their children/grandchildren or meet routine medical needs for themselves, their children, spouse/domestic partner, or elderly individuals with family-like relationships. Employees may take up to 4 hours per 30-day period or 24 hours per year for these purposes, with the leave being in addition to existing FMLA protections. This bill directly affects private sector employees covered by the FMLA and federal employees, broadening who qualifies for leave and expanding leave purposes to include family wellness activities.
The PROSPER Act of 2025 authorizes $25 million annually (2026-2030) from juvenile justice funds to award grants for youth gun violence prevention programs. It directly affects at-risk youth by requiring grantees to implement evidence-based strategies focused on trauma healing, youth empowerment, mental health connections, community engagement, and gun safety education. Key provisions mandate that programs must be culturally competent, trauma-informed, and inclusive of youth with past exposure to violence or the justice system. Eligible recipients include community organizations, tribes, colleges, and nonprofits - not law enforcement agencies.
Alternatives to Prevent Addiction In the Nation Act or the Alternatives to PAIN Act This bill reduces cost-sharing and prohibits the imposition of certain utilization requirements under the Medicare prescription drug benefit for certain non-opioid pain management drugs. Specifically, the bill requires such drugs to be covered without a deductible and to be placed on the lowest cost-sharing tier (if any). The bill also prohibits the imposition of prior authorization requirements (i.e., requiring prior approval from a plan) or step therapy requirements (i.e., requiring the use of alternative drugs before a drug is covered under a plan) with respect to such drugs.
The HSA Modernization Act (HR 548) expands eligibility for Health Savings Accounts (HSAs) by removing barriers for specific groups. It allows veterans without service-connected disabilities, Medicare Part A beneficiaries (age 65+), and individuals receiving Indian Health Service care to contribute to HSAs. The bill also permits bronze and catastrophic health plans (under the Affordable Care Act) to qualify as HSA-compatible plans, increases contribution limits to match deductible amounts, and enables both spouses to contribute to a single HSA with adjusted limits. All changes apply to taxable years beginning after December 31, 2025.
HR 1860 establishes Regional Breast Cancer and Gynecologic Cancer Care Coordinators within the VA to improve care coordination for veterans diagnosed with breast or reproductive system cancers (like cervical, ovarian, or uterine cancer) who receive treatment through the Veterans Community Care Program at non-VA facilities. These coordinators, reporting to the VA’s Breast and Gynecologic Oncology System of Excellence, will directly connect veterans with community care providers, monitor treatment outcomes, document care in electronic records, and provide veterans with information on emergency care and mental health resources. The bill requires the VA to create regional care coordination networks, prioritizing rural veterans’ needs, and mandates a 3-year report comparing health outcomes between VA and community care for these veterans. It focuses on streamlining care coordination rather than creating new benefits or funding.
This bill extends the Public Health and Bio-Preparedness Workforce Loan Repayment Program through fiscal years 2026 to 2030, replacing the previous 2023-2025 funding period. It directly affects public health workers (such as epidemiologists, laboratory staff, and emergency response personnel) who have federal student loans. The key provision reauthorizes existing funding to help these workers repay student debt by providing federal reimbursements. This maintains a critical workforce retention tool for agencies like the CDC and state health departments without creating new benefits or altering eligibility. The change is procedural, solely adjusting the program's funding timeline.
HR 1436, the ENABLE Act, makes permanent key tax provisions for ABLE accounts - tax-advantaged savings accounts for people with disabilities. It removes the 2026 expiration date for increased contribution limits to ABLE accounts and allows rollovers from 529 college savings plans into ABLE accounts without tax penalties. These changes directly affect individuals with disabilities who use ABLE accounts for qualified expenses like housing, education, and medical costs. The bill ensures these financial tools remain available long-term, streamlining access to savings without requiring new legislative action each year.
Tags
People with Disabilities